Pharmaceutical firm to open office in Annapolis British company's first U.S. subsidiary expected to have 12 employees

November 19, 1993|By Consella A. Lee | Consella A. Lee,Staff Writer

In The Sun for Anne Arundel County on Friday, the incorrect date was given for a news conference announcing British Bio-technology Group's impending move to Annapolis.

The news conference is slated for 1:30 p.m. tomorrow.

The Sun regrets the error.

British Bio-technology Group plc, described as a major

international pharmaceutical company, will open its first U.S. subsidiary in the Power Technology Building in Annapolis.

The U.S. subsidiary of British Bio-technology Inc. will be a clinical research and regulatory office and will handle the company's U.S. in vestor relations.


While organizers of the news conference declined to discuss details of the move, Rosemary Duggins of the Anne Arundel Economic Development Corp. said the company will have about 12 employees.

Local government officials have set a news conference for 1:30 p.m. Thursday in Baltimore to announce the move.

Scheduled to attend are Peter McCann, vice president of British Bio-technology Inc.; Mark L. Wasserman, secretary of the Maryland Department of Economic and Employment Development; Robert R. Neall, Anne Arundel County executive; Michael S. Lofton, executive vice president of the Anne Arundel Economic Development Corporation; and Donald P. Hutchinson, president of the Greater Baltimore Committee.

British Bio-technology Group has portfolio of drugs used to in the treatment of cancer, inflammation, AIDS and other maladies.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.